BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 32184905)

  • 1. A 17-Gene Signature Predicted Prognosis in Renal Cell Carcinoma.
    Li F; Hu W; Zhang W; Li G; Guo Y
    Dis Markers; 2020; 2020():8352809. PubMed ID: 32184905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
    Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
    Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular Characterization of Renal Cell Carcinoma: A Potential Three-MicroRNA Prognostic Signature.
    Lokeshwar SD; Talukder A; Yates TJ; Hennig MJP; Garcia-Roig M; Lahorewala SS; Mullani NN; Klaassen Z; Kava BR; Manoharan M; Soloway MS; Lokeshwar VB
    Cancer Epidemiol Biomarkers Prev; 2018 Apr; 27(4):464-472. PubMed ID: 29440068
    [No Abstract]   [Full Text] [Related]  

  • 4. Systematic analysis of alternative splicing signature unveils prognostic predictor for kidney renal clear cell carcinoma.
    Song J; Liu YD; Su J; Yuan D; Sun F; Zhu J
    J Cell Physiol; 2019 Dec; 234(12):22753-22764. PubMed ID: 31140607
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Autophagy-related gene
    Xie L; Li H; Zhang L; Ma X; Dang Y; Guo J; Liu J; Ge L; Nan F; Dong H; Yan Z; Guo X
    Aging (Albany NY); 2020 Jan; 12(2):1828-1842. PubMed ID: 32003756
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Five-Gene Signature Predicts Prognosis in Patients with Kidney Renal Clear Cell Carcinoma.
    Zhan Y; Guo W; Zhang Y; Wang Q; Xu XJ; Zhu L
    Comput Math Methods Med; 2015; 2015():842784. PubMed ID: 26539246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A seven-gene signature model predicts overall survival in kidney renal clear cell carcinoma.
    Chen L; Xiang Z; Chen X; Zhu X; Peng X
    Hereditas; 2020 Sep; 157(1):38. PubMed ID: 32883362
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Construction and validation of an autophagy-related long noncoding RNA signature for prognosis prediction in kidney renal clear cell carcinoma patients.
    Yu J; Mao W; Xu B; Chen M
    Cancer Med; 2021 Apr; 10(7):2359-2369. PubMed ID: 33650306
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel 10 glycolysis-related genes signature could predict overall survival for clear cell renal cell carcinoma.
    Xing Q; Zeng T; Liu S; Cheng H; Ma L; Wang Y
    BMC Cancer; 2021 Apr; 21(1):381. PubMed ID: 33836688
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of epithelial-mesenchymal transition markers in clear cell renal cell carcinoma.
    Xu H; Xu WH; Ren F; Wang J; Wang HK; Cao DL; Shi GH; Qu YY; Zhang HL; Ye DW
    Aging (Albany NY); 2020 Jan; 12(1):866-883. PubMed ID: 31915310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of CCL5 on the immune cells infiltration and the prognosis of patients with kidney renal clear cell carcinoma.
    Bai S; Wu Y; Yan Y; Kang H; Zhang J; Ma W; Gao Y; Hui B; Li R; Zhang X; Ren J
    Int J Med Sci; 2020; 17(18):2917-2925. PubMed ID: 33173412
    [No Abstract]   [Full Text] [Related]  

  • 12. Integral Analysis of the RNA Binding Protein-associated Prognostic Model for Renal Cell Carcinoma.
    Qin X; Liu Z; Yan K; Fang Z; Fan Y
    Int J Med Sci; 2021; 18(4):953-963. PubMed ID: 33456353
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Construction autophagy-related prognostic risk signature combined with clinicopathological validation analysis for survival prediction of kidney renal papillary cell carcinoma patients.
    Fei H; Chen S; Xu C
    BMC Cancer; 2021 Apr; 21(1):411. PubMed ID: 33858375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A 44-gene set constructed for predicting the prognosis of clear cell renal cell carcinoma.
    Wang Y; Wang Y; Liu F
    Int J Mol Med; 2018 Dec; 42(6):3105-3114. PubMed ID: 30272265
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Gene Signature of Survival Prediction for Kidney Renal Cell Carcinoma by Multi-Omic Data Analysis.
    Hu F; Zeng W; Liu X
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31739630
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An eleven metabolic gene signature-based prognostic model for clear cell renal cell carcinoma.
    Wu Y; Wei X; Feng H; Hu B; Liu B; Luan Y; Ruan Y; Liu X; Liu Z; Wang S; Liu J; Wang T
    Aging (Albany NY); 2020 Nov; 12(22):23165-23186. PubMed ID: 33221754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive assessment gene signatures for clear cell renal cell carcinoma prognosis.
    Chang P; Bing Z; Tian J; Zhang J; Li X; Ge L; Ling J; Yang K; Li Y
    Medicine (Baltimore); 2018 Nov; 97(44):e12679. PubMed ID: 30383629
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of a prognostic immune-associated gene signature in clear cell renal cell carcinoma.
    Shen C; Liu J; Wang J; Zhong X; Dong D; Yang X; Wang Y
    Int Immunopharmacol; 2020 Apr; 81():106274. PubMed ID: 32044664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The miR(21/10b) ratio as a prognostic marker in clear cell renal cell carcinoma.
    Fritz HKM; Lindgren D; Ljungberg B; Axelson H; Dahlbäck B
    Eur J Cancer; 2014 Jul; 50(10):1758-1765. PubMed ID: 24793999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exploration of immune-related genes in high and low tumor mutation burden groups of chromophobe renal cell carcinoma.
    Li L; Chen X; Hao L; Chen Q; Liu H; Zhou Q
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32662515
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.